The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology
The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426066512?dgcid=rss_sd_all
The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426066512?dgcid=rss_sd_all
“The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology.” Annals of Oncology.
@article{article36298,
title = {The ESMO Scale for Clinical Actionability of Molecular Targets, version 2 (ESCAT v2): an evidence-based framework for ranking alterations as actionability and resistance biomarkers in precision oncology},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426066512?dgcid=rss_sd_all}
}